NewsBang
Search
Sign In
Sign In
Sources
4 Total Sources
AstraZeneca, Ionis See Shares Drop Up to 12% After Wainua Fails Pivotal Heart Trial
Left
100%
All
4
Left
4
STAT
5h ago
AstraZeneca, Ionis Heart Drug Wainua Fails Pivotal ATTR-CM Trial
CNBC
5h ago
AstraZeneca Stock Tumbles 8% After Heart Drug Wainua Fails Clinical Trial
CNBC
17h ago
AstraZeneca stock dives 9% after heart drug trial misses target
The Motley Fool
17h ago
Breakfast News: AstraZeneca's Heart Drug Flatlines | The Motley Fool